Invirase (saquinavir mesylate) Capsules and Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
February 2016
WARNINGS AND PRECAUTIONS
QT Interval Prolongation
Patients initiating therapy with INVIRASE/ritonavir:
An ECG...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts